Sopharma sells over half a million treasury shares

Vesela Lyubenova Stoeva Deputy Chairman of the Board of Directors Sopharma AD
Vesela Lyubenova Stoeva Deputy Chairman of the Board of Directors - Sopharma AD
0Comments

Sopharma AD has announced the sale of a significant portion of its treasury shares. On July 2, 2025, the company sold 518,619 repurchased shares. This transaction accounts for 0.29% of the company’s share capital and was executed on the Bulgarian Stock Exchange.

The total value of the shares sold amounted to BGN 3,640,994.86, with an average price per share of BGN 7.02.

Following this sale, Sopharma’s total number of treasury shares stands at 8,894,963, which represents 4.95% of the company’s share capital.

“Sopharma” AD is listed on both the Bulgarian Stock Exchange (SFA) and Warsaw Stock Exchange (SPH).



Leave a Reply

Your email address will not be published. Required fields are marked *

Related

Gian Maria Gros-Pietro Chairman of the Board of Directors of Intesa Sanpaolo Wikipedia

Intesa Sanpaolo participates in 2025 EU-wide banking transparency exercise

Intesa Sanpaolo has acknowledged the European Banking Authority’s (EBA) announcement regarding the 2025 EU-wide Transparency Exercise.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi completes acquisition of Vicebio, expanding respiratory vaccine portfolio

Sanofi has finalized its acquisition of Vicebio Ltd, a company specializing in vaccine development.

Geoff Martha   Chairman and CEO Medtronic plc

Medtronic board approves $0.71 cash dividend for Q3 fiscal year 2026

Medtronic plc announced that its board of directors has approved a cash dividend of $0.71 per ordinary share for the third quarter of fiscal year 2026.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.